Responsibilities grounded in NovaPharm's operating plan.
NovaPharm's business-plan materials describe Dr Nishita as an experienced pharmaceutical quality and regulatory professional with approximately 20 years of experience across quality systems, GMP and GDP compliance, audits, validation, data integrity, CAPA, pharmacovigilance support and regulatory liaison.
Her Chief Technology Officer responsibility covers technology governance and controlled digital systems. Her Responsible Person appointment is a distinct regulated responsibility and does not imply that she acts for the MHRA, grants approvals, or has prescribing, medical or clinical authority.
The owner has approved the public title. A formal appointment or equivalent controlled record for the applicable legal entity, authorisation and scope remains a documentary governance action. Dr Nishita is not presented as a statutory director or shareholder.